Related Experiment Video
Updated: May 10, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory biomarkers for predicting cardiovascular disease
Lee Stoner1, Adam A Lucero, Barry R Palmer
1School of Sport and Exercise, Massey University, Wellington, New Zealand.
Insights
Cardiovascular disease (CVD) involves complex inflammation and oxidative stress pathways. This review details inflammatory and oxidative stress biomarkers to assess CVD risk and guide treatment strategies.
Area of Science:
- Biochemistry
- Pathology
- Clinical Medicine
Background:
- Cardiovascular disease (CVD) pathology is intricate, involving inflammation and oxidative stress.
- Biomarkers for inflammation and oxidative stress aid in risk identification, treatment monitoring, and drug development for CVD.
Purpose of the Study:
- To review existing and emerging biomarkers related to inflammation and oxidative stress in CVD.
- To discuss the functions and prognostic value of these biomarkers.
Main Methods:
- Literature review of inflammatory biomarkers (cytokines, chemokines) and oxidative stress/antioxidant biomarkers.
- Analysis of biomarker functions and prognostic data.
Main Results:
- No single biomarker can accurately estimate absolute CVD risk due to disease complexity.
- Different biomarkers offer varying prognostic information and are suited for specific cardiovascular events.
Conclusions:
- A comprehensive set of biomarkers is crucial for understanding the specific nature of cardiovascular events.
- This review provides an overview of key biomarkers and their clinical relevance in CVD management.
Abstract:
The pathology of cardiovascular disease (CVD) is complex; multiple biological pathways have been implicated, including, but not limited to, inflammation and oxidative stress. Biomarkers of inflammation and oxidative stress may serve to help identify patients at risk for CVD, to monitor the efficacy of treatments, and to develop new pharmacological tools. However, due to the complexities of CVD pathogenesis there is no single biomarker available to estimate absolute risk of future cardiovascular events. Furthermore, not all biomarkers are equal; the functions of many biomarkers overlap, some offer better prognostic information than others, and some are better suited to identify/predict the pathogenesis of particular cardiovascular events. The identification of the most appropriate set of biomarkers can provide a detailed picture of the specific nature of the cardiovascular event. The following review provides an overview of existing and emerging inflammatory biomarkers, pro-inflammatory cytokines, anti-inflammatory cytokines, chemokines, oxidative stress biomarkers, and antioxidant biomarkers. The functions of each biomarker are discussed, and prognostic data are provided where available.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Inflammation: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

